Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

CV Sciences (CVSI) EBT Margin (2016 - 2025)

CV Sciences (CVSI) has disclosed EBT Margin for 13 consecutive years, with 11.43% as the latest value for Q4 2025.

  • Quarterly EBT Margin rose 2376.0% to 11.43% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 2.66% through Dec 2025, up 1097.0% year-over-year, with the annual reading at 2.66% for FY2025, 1097.0% up from the prior year.
  • EBT Margin hit 11.43% in Q4 2025 for CV Sciences, up from 11.73% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 137.56% in Q1 2023 to a low of 180.22% in Q4 2021.
  • Historically, EBT Margin has averaged 24.73% across 5 years, with a median of 15.16% in 2024.
  • Biggest five-year swings in EBT Margin: skyrocketed 17163bps in 2023 and later tumbled -15310bps in 2024.
  • Year by year, EBT Margin stood at 180.22% in 2021, then skyrocketed by 66bps to 61.05% in 2022, then skyrocketed by 62bps to 23.1% in 2023, then soared by 47bps to 12.33% in 2024, then soared by 193bps to 11.43% in 2025.
  • Business Quant data shows EBT Margin for CVSI at 11.43% in Q4 2025, 11.73% in Q3 2025, and 7.21% in Q2 2025.